Invention Grant
- Patent Title: Anti-glucagon antibodies
-
Application No.: US14855274Application Date: 2015-09-15
-
Publication No.: US09657099B2Publication Date: 2017-05-23
- Inventor: Haruka Okamoto , Jesper Gromada
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee Address: US NY Tarrytown
- Agency: Brownstein Hyatt Farber Schreck, LLP
- Agent Veronica Mallon; Cara L. Crowley-Weber
- Main IPC: C07K16/26
- IPC: C07K16/26 ; A61K39/395 ; A61K45/06 ; A61K39/00
Abstract:
The present invention provides antibodies that bind to glucagon and methods of using the same. According to certain embodiments, the antibodies of the invention bind human GCG with high affinity. The antibodies of the invention may be fully human antibodies. The antibodies of the invention are useful for the treatment of various diseases or disorders characterized by elevated blood glucose levels, as well as other GCG-related disorders.
Public/Granted literature
- US20160075778A1 Anti-Glucagon Antibodies and Uses Thereof Public/Granted day:2016-03-17
Information query
